About Schwerpunktpraxis für Entwicklung und Lernen
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Schwerpunktpraxis für Entwicklung und Lernen
During the past decade, Schwerpunktpraxis für Entwicklung und Lernen conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
2015-06-17
2020-06-17
Completed
1,012
An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
2015-12-02
2025-02-27
Active, not recruiting
878
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
2018-02-27
2024-06-28
Recruiting
600
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
2018-06-27
2025-06-24
Recruiting
485
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
2018-08-24
2029-12-27
Recruiting
1,200
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Schwerpunktpraxis für Entwicklung und Lernen
According to Clinical.Site data, the most researched conditions in "Schwerpunktpraxis für Entwicklung und Lernen" are
"ADHD" (1 trials), "Attention Deficit Hyperactivity Disorder (ADHD)" (1 trials) and "Attention-Deficit/Hyperactivity Disorder" (1 trials). Many other conditions were trialed in "Schwerpunktpraxis für Entwicklung und Lernen" in a lesser frequency.
Clinical Trials Intervention Types at Schwerpunktpraxis für Entwicklung und Lernen
Most popular intervention types in "Schwerpunktpraxis für Entwicklung und Lernen" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Atomoxetine Hydrochloride" (1 trials), "Lisdexamfetamine Dimesylate" (1 trials), "Lisdexamfetamine dimesylate" (1 trials), "Lisdexamfetamine dimesylate (LDX)" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Schwerpunktpraxis für Entwicklung und Lernen
The vast majority of trials in "Schwerpunktpraxis für Entwicklung und Lernen" are
3 trials for "All" genders.
Clinical Trials Status at Schwerpunktpraxis für Entwicklung und Lernen
Currently, there are NaN active trials in "Schwerpunktpraxis für Entwicklung und Lernen".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Schwerpunktpraxis für Entwicklung und Lernen,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Schwerpunktpraxis für Entwicklung und Lernen, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".